[Intoxications by hallucinogenic mushrooms].
In the context of excessive use of natural or synthetic psychoactive substances, with stimulating, psychedelic and hallucinogenic effects, an increase, if not a recurrence, in consumption of Psilocybe semilanceata has been observed in France over some fifteen years. Psilocybin and psilocin are the active compounds, responsible for the hallucinogenic effects and are a part of the substance group, derived from tryptamine and characterized by an indole nucleus. We report a clinical case observed in an emergency unit and review the historical, epidemiological and pharmacological data now available for these intoxications. Of particular interests in hallucinogenic mushroom abuse are: increased consumption in the context of youth cultural and entertainment movements; possible difficulties in the diagnosis in emergency conditions; possibility of severe and fatal complications.
Pierrot
M
M
Centre Anti-Poison, Centre d'Evaluation et d'Information sur la Pharmacodépendance, CHU, 29, avenue Maréchal-de-Lattre-de-Tassigny, CO n degrees 34, 54035 Nancy Cedex.
Josse
P
P
Raspiller
M F
MF
Goulmy
M
M
Rambourg
M O
MO
Manel
J
J
Lambert
H
H
D000328:Adult; D005500:Follow-Up Studies; D006213:Hallucinogens / Q000506:poisoning*; D006801:Humans; D008297:Male; D009145:Mushroom Poisoning / Q000175:diagnosis; D011562:Psilocybin / Q000506:poisoning*; D013997:Time Factors
D006213:Hallucinogens; D011562:Psilocybin